Indo Nippon: A New Sun Rises To Link Indian And Japanese Drug Firms
This article was originally published in PharmAsia News
Executive Summary
In search of business opportunities, several Indian and Japanese drug makers have come under one roof to identify joint projects. The architect of the new initiative is Satish Khanna, an industry veteran who has seen successes with similar ventures in the past.